K192876 is an FDA 510(k) clearance for the INTELLIO Tablet Application. This device is classified as a Endoscopic Central Control Unit (Class II - Special Controls, product code ODA).
Submitted by Smith & Nephew (Andover, US). The FDA issued a Cleared decision on February 27, 2020, 142 days after receiving the submission on October 8, 2019.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1500. To Control Endoscopic And Other Ancillary Surgical Equipment In One Central Location, Either By Remote Control, Touch Screen, Or Voice Command..